Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.
about
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infantsProphylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infantsProphylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infantsCandida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysisEpidemiology of invasive candidiasis: a persistent public health problemFluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsRegional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.Fungal PDR transporters: Phylogeny, topology, motifs and function.Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemiaSecular trend in candidemia and the use of fluconazole in Finland, 2004-2007The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.Candida parapsilosis, an emerging fungal pathogenEfficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study.A review of Candida prophylaxis in the neonatal intensive care population.Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.Antibiotics and antifungals in neonatal intensive care units: a review.Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients.Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibilityCandida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study.Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?Invasive fungal infections in newborns and current management strategies.Uncommon opportunistic fungal infections of oral cavity: A review.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface.Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory-based sentinel surveillance, South Africa, 2009-2010.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data.Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.Transcriptional profiling of azole-resistant Candida parapsilosis strainsPrevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection.Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.
P2860
Q24186385-4BCF92ED-0044-4211-BFA1-CB5BE6EA7614Q24197610-66E64108-15C5-46DC-8855-EA7CBE1EC4B1Q24243140-F7974EC5-A1B9-4FD1-A95A-E1EA6A3DD0BEQ28533912-3074E82B-8A23-4D5D-B8C9-D9033D93FF62Q29616758-07080643-BE4D-4A2B-8B42-4DAF890BED2CQ30276620-9C9E2D81-877C-4860-8BE4-3F0C5454B41CQ30435365-57EDADE9-C024-44C1-980F-02C43AE3F04DQ30826889-9C001F14-DBCE-4D20-81B7-DE0E83338EB9Q33394366-5EB09EA3-5C30-4D28-B60F-24B88D53970DQ33624643-3B12F431-D691-426A-930E-175668760FE9Q34022724-B672FF2C-EE90-4745-A387-9EA0A079788EQ34332272-412F193F-7553-4995-B1FB-1D7707B2B221Q34586566-CB21CFB5-7DB2-4850-A6D3-EC63FD7FA4EAQ34852747-9A8DA12F-A486-4EDC-B4CD-98B5F87C7E35Q36019197-D30FAC33-025B-458F-8E2D-BE5D923BDD88Q36063798-ECF3A0F9-4E4E-4A82-B519-414A80909F90Q36401437-D237B2FA-00F4-4167-B817-67B29DE31031Q36497888-C8ADBEB4-A3E2-494F-9EBE-1283FB9904C9Q36728707-2E2F9C4E-A71C-4227-8C47-D6FFD3E156B6Q36740036-70084681-FA33-482E-834D-C55224E1EC39Q36838766-40A81BED-FE81-4CDB-8BEE-DBB7FBDCB725Q37302110-1C7E5187-7F8B-4723-B99A-8FE426F9F9E8Q37544444-C1262F53-4A0F-47CC-97E5-7B466FAC0BB2Q37613000-C0D5BC0C-6FA2-4219-B719-75E616F59B35Q37696411-B025FFC9-831B-4B19-B3A7-01BE3D843741Q37854724-4E7FDCA9-9AB6-41C4-B7F4-2602352A74A1Q38119554-1A9B8A1D-B861-41AA-B442-C08E326A0A08Q38261303-D2ABC82F-815D-4EE1-AF94-FEA2BFB48E3EQ38589279-795ECCC7-3A4F-42F4-937C-DC347D68AB6AQ38659451-AEC55502-5A40-4C1C-81FB-8D9ACBC72479Q39203378-2D11A951-231F-464D-A29A-312720778DE0Q39899742-D57C642D-80AE-4CAA-B075-132B98978DC5Q40051828-BE7A295D-47BB-41F4-96D5-5DBE7E924F62Q40640348-FB84239A-1B3E-4ED6-A8ED-175B6DBE754CQ41838145-6536E585-0662-4CE4-AA19-BBA41CB7B1AFQ42062440-C4D68CEA-CA3F-40E4-88CF-C030127A99CEQ42110990-799BFD88-917A-48D3-9B4C-528870914024Q42515150-5D1E1043-EDAC-4D97-A349-60D8EA344589Q42549201-99D1617C-AF87-4636-BA99-D702B5FCD0C0Q42846077-CE081CCF-E91E-4031-96C3-E9A281572BB2
P2860
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Emergence of fluconazole resis ...... neonatal intensive care unit.
@ast
Emergence of fluconazole resis ...... neonatal intensive care unit.
@en
type
label
Emergence of fluconazole resis ...... neonatal intensive care unit.
@ast
Emergence of fluconazole resis ...... neonatal intensive care unit.
@en
prefLabel
Emergence of fluconazole resis ...... neonatal intensive care unit.
@ast
Emergence of fluconazole resis ...... neonatal intensive care unit.
@en
P2093
P2860
P1476
Emergence of fluconazole resis ...... neonatal intensive care unit.
@en
P2093
Claude Pujol
David R Soll
Emmi Sarvikivi
Harri Saxén
Malcolm Richardson
Pirkko Koukila-Kähkölä
Päivi Luukkainen
P2860
P304
P356
10.1128/JCM.43.6.2729-2735.2005
P407
P577
2005-06-01T00:00:00Z